Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00220
|
|||||
| Drug Name |
Eliglustat tartrate
|
|||||
| Synonyms |
Fabrazyme (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Metabolic disorders [ICD11: 5C50] | Approved | [1] | |||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C50H78N4O14
|
|||||
| Canonical SMILES |
CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O.CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O.C(C(C(=O)O)O)(C(=O)O)O
|
|||||
| InChI |
InChI=1S/2C23H36N2O4.C4H6O6/c2*1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20;5-1(3(7)8)2(6)4(9)10/h2*10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26);1-2,5-6H,(H,7,8)(H,9,10)/t2*19-,23-;1-,2-/m111/s1
|
|||||
| InChIKey |
KUBARPMUNHKBIQ-VTHUDJRQSA-N
|
|||||
| CAS Number |
CAS 104138-64-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 959.2 | Topological Polar Surface Area | 257 | ||
| Heavy Atom Count | 68 | Rotatable Bond Count | 25 | |||
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 16 | |||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:83353
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Eliglustat tartrate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
